Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Amicus Therapeutics (FOLD) Depreciation & Amortization (IS) (2018 - 2025)

Amicus Therapeutics' Depreciation & Amortization (IS) history spans 13 years, with the latest figure at $1.9 million for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (IS) fell 7.06% year-over-year to $1.9 million, compared with a TTM value of $7.5 million through Dec 2025, down 12.72%, and an annual FY2025 reading of $7.5 million, down 12.72% over the prior year.
  • Depreciation & Amortization (IS) for Q4 2025 was $1.9 million at Amicus Therapeutics, up from $1.9 million in the prior quarter.
  • The five-year high for Depreciation & Amortization (IS) was $2.2 million in Q3 2023, with the low at $1.3 million in Q1 2023.
  • Average Depreciation & Amortization (IS) over 5 years is $1.8 million, with a median of $1.8 million recorded in 2025.
  • Year-over-year, Depreciation & Amortization (IS) plummeted 40.4% in 2021 and then skyrocketed 73.25% in 2023.
  • Tracing FOLD's Depreciation & Amortization (IS) over 5 years: stood at $1.5 million in 2021, then dropped by 13.64% to $1.3 million in 2022, then soared by 66.44% to $2.2 million in 2023, then dropped by 6.46% to $2.0 million in 2024, then fell by 7.06% to $1.9 million in 2025.
  • Per Business Quant, the three most recent readings for FOLD's Depreciation & Amortization (IS) are $1.9 million (Q4 2025), $1.9 million (Q3 2025), and $1.9 million (Q2 2025).